BusinessWeek reports that some companies are now making it possible for people to buy products that are NOT made in China. For example, Swiss ingredient maker DSM Nutritional Products launched a "premium" Vitamin C that's made in Scotland rather than China, which provides 80% of the world's supply. Now DSM's Quali-C Vitamin C brand is benefiting from consumer's reluctance to buy Chinese products in the wake of the contamination incidents.

Here are three other companies likely to benefit from this anywhere-but- China sentiment:

• Fairway, an upscale New York grocery, reassures consumers that none of its seafood is Chinese;
• International Business Machines Corp. (NYSE: IBM) is pushing systems to trace the food supply from source to market so that people will know where their products come from;
  
• Freshpet, a Secaucus, NJ all-natural producer of premium dog food blended from meat and vegetables has seen its distribution increase from 200 stores to 1,000 stores, with another 1,000 coming by the end of 2007, tripling its sales to $50 million.

I sense an opportunity for a publicly-traded purveyor of anywhere-but-China consumer products -- maybe Freshpet can do an IPO. It looks to me like IBM's offering will not grow to be big enough to make a significant boost to its corporate profits.

Peter Cohan is president of Peter S. Cohan & Associates, a management consulting and venture capital firm. He also teaches management at Babson College and edits The Cohan Letter. He has no financial interest in IBM.